I think they did a good job of answering all the questions that were asked and explaining the path forward. Collect data and seek a BP partner to help commercialise is the plan.
They’re clearly not in a strong position to raise at the minute but they have no choice. They can’t telegraph capital raises nor disclose who participates and they’re definitely not in a position to dictate terms unfortunately.
They confirmed the cost of the phase 2/3 trial for Azer Cell, the timeline and that it’s our best and most likely path to initial commercial success.
I encourage you to watch the webinar again, I did yesterday and found it reassuring.
IMU Price at posting:
1.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)